Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dorman Products, Inc.DORM · Entity 4084 | Director | June 01, 2026 | June 03, 2026 |
| LeonaBio, Inc.LONA · Entity 1487 | Director | June 23, 2026 | June 24, 2026 |
| UGI CORP /PA/UGI · Entity 3628 | Director | January 30, 2026 | February 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dorman Products, Inc.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,172 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 1,344 · Balance 12,172 F1: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.
LeonaBio, Inc.
Report date June 23, 2026 · Filed June 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.35 · Expires 2036-06-22 | Direct | 28,000 |
Reported balance
After 2026-06-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 28,000 · Balance 28,000 F1: The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.
UGI CORP /PA/
Report date January 30, 2026 · Filed February 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| UGI Common StockSEC Table I · non-derivative | IndirectBenefit Plan | 30,005 |
Reported balance
After 2026-01-30 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-01-30 · Grant · Acquired 4,364 · Balance 30,005 F1: Total gives effect to dividend equivalent accruals. F2: Effective January 30, 2026, the reporting person was granted Stock Units under the UGI Corporation 2021 Incentive Award Plan. Each Stock Unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: Total gives effect to dividend equivalent accruals.
F2: Effective January 30, 2026, the reporting person was granted Stock Units under the UGI Corporation 2021 Incentive Award Plan. Each Stock Unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2026 Filed Jun 24, 2026 22:31 UTC | LeonaBio, Inc. LONA · Entity 1487 | GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $8.35 | $0.00 |
DisclosureSEC source: 0001722055-26-000005 · form4-06242026_100643.xml · derivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-06-22 F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:19 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,344 | $122.71 | $164,922.24 |
DisclosureSEC source: 0001628280-26-040513 · wk-form4_1780521589.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,172 F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. Read SEC document |
| May 15, 2026 Filed May 19, 2026 20:02 UTC | Dorman Products, Inc. DORM · Entity 4084 | Tax withholdingCommon Stock | 33 | $116.16 | $3,833.28 |
DisclosureSEC source: 0001628280-26-036366 · wk-form4_1779220949.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,828 F1 · shares: These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 09, 2026 Filed Apr 13, 2026 20:54 UTC | LeonaBio, Inc. LONA · Entity 1487 | GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $9.54 | $0.00 |
DisclosureSEC source: 0001722055-26-000004 · form4-04132026_080426.xml · derivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2036-04-08 F1 · derivative.exercise_date: The shares subject to the option shall be scheduled to vest monthly over a term of 24 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates. Read SEC document |
| January 30, 2026 Filed Feb 3, 2026 21:11 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 4,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001722055-26-000002 · form4-02032026_090240.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Benefit Plan Disclosed balance after: 30,005 F1 · balance_after: Total gives effect to dividend equivalent accruals. F2 · ownership.nature: Effective January 30, 2026, the reporting person was granted Stock Units under the UGI Corporation 2021 Incentive Award Plan. Each Stock Unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:12 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-029319 · wk-form4_1749067775.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,861 F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:35 UTC | LeonaBio, Inc. ATHA · Entity 1487 | GrantStock Option (Right to Buy) · Derivative | 20,900 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001415889-25-015439 · form4-06032025_090622.xml · derivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,900 Underlying: Common Stock · 20,900 shares Expires 2035-05-29 F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 30, 2026, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 30, 2025. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy. Read SEC document |
| May 16, 2025 Filed May 20, 2025 17:12 UTC | Dorman Products, Inc. DORM · Entity 4084 | Tax withholdingCommon Stock | 46 | $132.03 | $6,073.38 |
DisclosureSEC source: 0001628280-25-026762 · wk-form4_1747761120.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,791 F1 · shares: These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:48 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 5,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002992 · form4-02042025_100213.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Benefit Plan Disclosed balance after: 24,652 F1 · balance_after: Total gives effect to dividend equivalent accruals. F2 · ownership.nature: Effective January 31, 2025, the reporting person was granted Stock Units under the UGI Corporation 2021 Incentive Award Plan. Each stock unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| June 24, 2024 Filed Jun 25, 2024 23:21 UTC | LeonaBio, Inc. ATHA · Entity 1487 | PurchaseCommon Stock | 27,400 | $2.42 | $66,179.22 |
DisclosureSEC source: 0001415889-24-018177 · form4-06252024_110651.xml · nonDerivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,715 F2 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.39 to $2.43, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range. Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 23:21 UTC | LeonaBio, Inc. ATHA · Entity 1487 | PurchaseCommon Stock | 15,000 | $2.26 | $33,871.50 |
DisclosureSEC source: 0001415889-24-018177 · form4-06252024_110651.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,315 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.20 to $2.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 16:09 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-026499 · wk-form4_1717517355.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,837 F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. Read SEC document |
| May 24, 2024 Filed May 24, 2024 23:03 UTC | LeonaBio, Inc. ATHA · Entity 1487 | GrantStock Option (Right to Buy) · Derivative | 20,900 | $0.00 Strike: $2.64 | $0.00 |
DisclosureSEC source: 0001415889-24-014582 · form4-05242024_110538.xml · derivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,900 Underlying: Common Stock · 20,900 shares Expires 2034-05-23 F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 24, 2025, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 24, 2024. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy. Read SEC document |
| May 17, 2024 Filed May 21, 2024 14:01 UTC | Dorman Products, Inc. DORM · Entity 4084 | Tax withholdingCommon Stock | 47 | $91.33 | $4,292.51 |
DisclosureSEC source: 0001628280-24-024467 · wk-form4_1716300102.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,366 F1 · shares: These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:27 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantOptions (Right to Buy) · Derivative | 12,890 | $0.00 Strike: $23.17 | $0.00 |
DisclosureSEC source: 0000884614-24-000026 · wk-form4_1706650020.xml · derivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,890 Underlying: UGI Common Stock · 12,890 shares Expires 2034-01-25 F3 · shares: These options were granted under the UGI Corporation 2021 Incentive Award Plan and are fully vested on the effective date of the grant. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 21:27 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 4,470 | $0.00 | $0.00 |
DisclosureSEC source: 0000884614-24-000026 · wk-form4_1706650020.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Benefit Plan Disclosed balance after: 18,001 F1 · balance_after: Total gives effect to dividend equivalent accruals. F2 · ownership.nature: Effective January 26, 2024, the reporting person was granted Stock Units under the UGI Corporation 2021 Incentive Award Plan. Each stock unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 18:48 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033611 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,413 F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. Read SEC document |
| May 19, 2023 Filed May 22, 2023 22:11 UTC | LeonaBio, Inc. ATHA · Entity 1487 | GrantStock Option (Right to Buy) · Derivative | 20,900 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001209191-23-031580 · doc4.xml · derivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,900 Underlying: Common Stock · 20,900 shares Expires 2033-05-18 F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 19, 2024, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 19, 2023. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy. Read SEC document |
| May 18, 2023 Filed May 22, 2023 14:42 UTC | Dorman Products, Inc. DORM · Entity 4084 | Tax withholdingCommon Stock | 38 | $86.54 | $3,288.52 |
DisclosureSEC source: 0001209191-23-031348 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,903 F1 · shares: These shares were withheld by the issuer upon the vesting of restricted stock units to satisfy the reporting person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 22:51 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantOptions (Right to Buy) · Derivative | 5,670 | $0.00 Strike: $39.81 | $0.00 |
DisclosureSEC source: 0000884614-23-000015 · wf-form4_167520549818039.xml · derivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,670 Underlying: UGI Common Stock · 5,670 shares Expires 2033-01-26 F3 · shares: These options were granted under the UGI Corporation 2021 Incentive Award Plan and are fully vested on the effective date of the grant. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 22:51 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000884614-23-000015 · wf-form4_167520549818039.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Benefit Plan Disclosed balance after: 12,761 F1 · balance_after: Total gives effect to dividend equivalent accruals. F2 · ownership.nature: Effective January 27, 2023, the reporting person was granted Stock Units under the UGI Corporation 2021 Incentive Award Plan. Each stock unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| December 02, 2022 Filed Dec 7, 2022 01:31 UTC | LeonaBio, Inc. ATHA · Entity 1487 | PurchaseCommon Stock | 30,000 | $3.29 | $98,700.00 |
DisclosureSEC source: 0001209191-22-060128 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,315 F1 · price: The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.23 to $3.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within such range. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 18:32 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,223 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033437 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,941 F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. Read SEC document |
| May 25, 2022 Filed May 27, 2022 13:38 UTC | Dorman Products, Inc. DORM · Entity 4084 | Tax withholdingCommon Stock | 33 | $98.06 | $3,235.98 |
DisclosureSEC source: 0001209191-22-032399 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,718 F1 · shares: These shares were withheld by the issuer upon the vesting of restricted stock units to satisfy the reporting person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 20, 2022 Filed May 27, 2022 21:49 UTC | LeonaBio, Inc. ATHA · Entity 1487 | GrantStock Option (Right to Buy) · Derivative | 13,871 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001209191-22-032696 · doc4.xml · derivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,871 Underlying: Common Stock · 13,871 shares Expires 2032-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) May 20, 2023, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 20, 2022. The option reported was granted pursuant to the terms of the Issuer's outside director compensation policy. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:40 UTC | LeonaBio, Inc. ATHA · Entity 1487 | PurchaseCommon Stock | 8,000 | $13.11 | $104,880.00 |
DisclosureSEC source: 0001209191-22-022001 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,315 Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 22:24 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantOption (Right to Buy) · Derivative | 2,300 | $0.00 Strike: $44.97 | $0.00 |
DisclosureSEC source: 0001209191-22-005962 · doc4.xml · derivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Underlying: UGI Common Stock · 2,300 shares Expires 2032-01-27 F3 · shares: These options were granted under the UGI Corporation 2021 Incentive Award Plan and are fully vested on the effective date of the grant. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 22:24 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 6,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-005962 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Benefit Plan Disclosed balance after: 13,534 F1 · balance_after: Total gives effect to dividend equivalent accruals. F2 · ownership.nature: Effective January 28, 2022, the reporting person was granted Stock Units under the UGI Corporation 2021 Incentive Award Plan. Each stock unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| January 28, 2022 Filed Feb 4, 2022 21:55 UTC Amendment | UGI CORP /PA/ UGI · Entity 3628 | GrantOptions (Right to Buy) · Derivative | 6,050 | $0.00 Strike: $44.97 | $0.00 |
DisclosureSEC source: 0001209191-22-007219 · doc4a.xml · derivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,050 Underlying: UGI Common Stock · 6,050 shares Expires 2032-01-27 F1 · shares: This Form 4 amendment is being filed solely to correct an administrative error, which resulted in the misreporting of the number of stock units and stock options granted to the reporting person on January 28, 2022. F4 · shares: These options were granted under the UGI Corporation 2021 Incentive Award Plan and are fully vested on the effective date of the grant. Read SEC document |
| January 28, 2022 Filed Feb 4, 2022 21:55 UTC Amendment | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007219 · doc4a.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Benefit Plan Disclosed balance after: 9,784 F1 · shares: This Form 4 amendment is being filed solely to correct an administrative error, which resulted in the misreporting of the number of stock units and stock options granted to the reporting person on January 28, 2022. F2 · balance_after: Total gives effect to dividend equivalent accruals. F3 · ownership.nature: Effective January 28, 2022, the reporting person was granted stock units under the UGI Corporation 2021 Incentive Award Plan. Each stock unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 13:49 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037508 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,751 F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. Read SEC document |
| May 13, 2021 Filed May 17, 2021 14:30 UTC | Dorman Products, Inc. DORM · Entity 4084 | Tax withholdingCommon Stock | 44 | $103.03 | $4,533.32 |
DisclosureSEC source: 0001209191-21-033031 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,687 F1 · shares: These shares were withheld by the issuer upon the vesting of restricted stock units to satisfy the reporting person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 23:24 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantOption (Right to Buy) · Derivative | 8,860 | $0.00 Strike: $35.99 | $0.00 |
DisclosureSEC source: 0001209191-21-006920 · doc4.xml · derivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,860 Underlying: UGI Common Stock · 8,860 shares Expires 2031-01-28 F3 · shares: These options were granted under the UGI Corporation 2013 Omnibus Incentive Compensation Plan and are fully vested on the effective date of the grant. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 23:24 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 2,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006920 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Benefit Plan Disclosed balance after: 7,268 F1 · balance_after: Total gives effect to dividend equivalent accruals. F2 · ownership.nature: Effective January 29, 2021, the reporting person was granted Stock Units under the UGI Corporation 2013 Omnibus Incentive Compensation Plan. Each stock unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| December 22, 2020 Filed Jan 9, 2021 02:49 UTC | LeonaBio, Inc. ATHA · Entity 1487 | OtherCommon Stock | 315 | $31.74 | $9,999.08 |
DisclosureSEC source: 0001209191-21-002855 · doc5.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 00:24 UTC | LeonaBio, Inc. ATHA · Entity 1487 | GrantStock Option (Right to Buy) · Derivative | 27,742 | $0.00 Strike: $29.41 | $0.00 |
DisclosureSEC source: 0001209191-20-063347 · doc4.xml · derivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,742 Underlying: Common Stock · 27,742 shares Expires 2030-12-10 F1 · derivative.exercise_date: One thirty-sixth of the shares subject to the option will vest on January 11, 2021 and one thirty-sixth of the shares subject to the option will vest each month thereafter. Read SEC document |
| July 02, 2020 Filed Jul 6, 2020 21:27 UTC | Dorman Products, Inc. DORM · Entity 4084 | Tax withholdingCommon Stock | 36 | $66.67 | $2,400.12 |
DisclosureSEC source: 0001209191-20-041071 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,731 F1 · shares: These shares were withheld by the issuer upon the vesting of a restricted stock award to satisfy the reporting person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 12:24 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033806 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,767 F1 · shares: Grant of restricted stock units representing a contingent right to receive shares of Dorman common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:45 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantOption (Right to Buy) · Derivative | 9,060 | $0.00 Strike: $43.89 | $0.00 |
DisclosureSEC source: 0001209191-20-004858 · doc4.xml · derivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,060 Underlying: UGI Common Stock · 9,060 shares Expires 2030-01-21 F3 · shares: These options were granted under the UGI Corporation 2013 Omnibus Incentive Compensation Plan and are fully vested on the effective date of the grant. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:45 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-004858 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Benefit Plan Disclosed balance after: 4,239 F1 · balance_after: Total gives effect to dividend equivalent accruals. F2 · ownership.nature: Effective January 22, 2020, the reporting person was granted Stock Units under the UGI Corporation 2013 Omnibus Incentive Compensation Plan. Each stock unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 17:40 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040808 · doc4.xml · nonDerivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,338 Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 17:40 UTC | Dorman Products, Inc. DORM · Entity 4084 | Tax withholdingCommon Stock | 41 | $87.52 | $3,588.32 |
DisclosureSEC source: 0001209191-19-040808 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,180 F1 · shares: These shares were withheld by the issuer upon the vesting of a restricted stock award to satisfy Ms. Romano's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 22:17 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantOption (Right to Buy) · Derivative | 5,400 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001209191-19-006527 · doc4.xml · derivative · entry 2 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Underlying: UGI Common Stock · 5,400 shares Expires 2029-01-29 Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 22:17 UTC | UGI CORP /PA/ UGI · Entity 3628 | GrantUGI Common Stock | 1,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006527 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Benefit Plan Disclosed balance after: 1,840 F1 · ownership.nature: Effective January 30, 2019, the reporting person was granted Stock Units under the UGI Corporation 2013 Omnibus Incentive Compensation Plan. Each stock unit represents the right of the recipient to receive a share of Common Stock upon retirement or termination of service. Read SEC document |
| July 01, 2018 Filed Jul 2, 2018 21:30 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 1,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-040445 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,221 Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 18:47 UTC | Dorman Products, Inc. DORM · Entity 4084 | GrantCommon Stock | 903 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-060227 · doc4.xml · nonDerivative · entry 1 Romano Kelly A · CIK 0001722055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 903 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.